Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity
- 1 August 1994
- journal article
- review article
- Published by Springer Nature in Virchows Archiv
- Vol. 425 (1) , 3-24
- https://doi.org/10.1007/bf00193944
Abstract
Granulation tissue fibroblasts (myofibroblasts) develop several ultrastructural and biochemical features of smooth muscle (SM) cells, including the presence of microfilament bundles and the expression of α-SM actin, the actin isoform present in SM cells and myoepithelial cells and particularly abundant in vascular SM cells. Myofibroblasts have been suggested to play a role in wound contraction and in retractile phenomena observed during fibrotic diseases. When contraction stops and the wound is fully epithelialized, myofibroblasts containing α-SM actin disappear, probably as a result of apoptosis, and the scar classically becomes less cellular and composed of typical fibroblasts with well-developed rough endoplasmic reticulum but with no more microfilaments. In contrast, α-SM actin expressing myofibroblasts persist in hypertrophic scars and in fibrotic lesions of many organs, including stroma reaction to epithelial tumours, where they are allegedly involved in retractile phenomena as well as in extracellular matrix accumulation. The mechanisms leading to the development of myofibroblastic features remain to be investigated. In vivo and in vitro investigations have shown that γ-interferon exerts an antifibrotic activity at least in part by decreasing α-SM actin expression whereas heparin increases the proportion of α-SM actin positive cells. Recently, we have observed that the subcutaneous administration of transforming growth factor-β1 to rats results in the formation of a granulation tissue in which α-SM actin expressing myofibroblasts are particularly abundant. Other cytokines and growth factors, such as platelet-derived growth factor, basic fibroblast growth factor and tumour necrosis factor-α, despite their profibrotic activity, do not induce α-SM actin in myofibroblasts. In conclusion, fibroblastic cells are relatively undifferentiated and can assume a particular phenotype according to the physiological needs and/or the microenvironmental stimuli. Further studies on fibroblast adaptation phenomena appear to be useful for the understanding of the mechanisms of development and regression of pathological processes such as wound healing and fibrocontractive diseases.Keywords
This publication has 98 references indexed in Scilit:
- Phenotypic features of stromal cells in normal, premalignant and malignant conditionsEuropean Journal Of Cancer, 1992
- Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development.Genes & Development, 1992
- Transforming growth factor‐β1 is a heparin‐binding protein: Identification of putative heparin‐binding regions and isolation of heparins with varying affinity for TGF‐β1Journal of Cellular Physiology, 1992
- Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-PZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Platelet-derived growth factor in Dupuytren's diseaseThe Journal of Hand Surgery, 1992
- Appearance of α‐smooth‐muscle‐actin‐positive cells in hepatic fibrosisLiver International, 1991
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- Nonmuscle and smooth muscle myosin isoforms in bovine endothelial cellsExperimental Cell Research, 1990
- At least six different actins are expressed in a higher mammal: An analysis based on the amino acid sequence of the amino-terminal tryptic peptideJournal of Molecular Biology, 1978